Lars Erichsen
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Epigenetics and DNA Methylation 10
- Renal and related cancers 4
-
- Diabetes Management and Research 5
- Diabetes Treatment and Management 3
- Co-authors
- Hanne Haahr (5 shared papers)Sue D. Pedersen (2 shared papers)Thomas Danne (2 shared papers)Thomas R. Pieber (4 shared papers)Kristian Vinter Juul (2 shared papers)Tim Heise (3 shared papers)Chantal Mathieu (2 shared papers)Melanie J. Davies (1 shared paper)
- Journals
- International Journal of Molecular Sciences (6 papers)Cells (4 papers)Scientific Reports (3 papers)The Lancet (2 papers)Die Naturwissenschaften (2 papers)
- Partner nations
- GermanyDenmarkUnited States
In The Last Decade
Lars Erichsen
44 papers receiving 1.1k citations
Lars Erichsen's Hit Papers
Peers
Comparison fields: 5 of 124
- Endocrinology, Diabetes and Metabolism 528
- Pharmacology 164
- Urology 47
- Endocrine and Autonomic Systems 43
- Physiology 152
Countries citing papers authored by Lars Erichsen
This map shows the geographic impact of Lars Erichsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Erichsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Erichsen more than expected).
Fields of papers citing papers by Lars Erichsen
This network shows the impact of papers produced by Lars Erichsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Erichsen. The network helps show where Lars Erichsen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Erichsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial Hit paper breakdown → | 2023 | 214 |
| 2 | Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Hit paper breakdown → | 2021 | 185 |
| 3 | 2017 | 137 | |
| 4 | 2011 | 105 | |
| 5 | 2017 | 59 | |
| 6 | 2018 | 38 | |
| 7 | 2020 | 34 | |
| 8 | 2018 | 27 | |
| 9 | 2003 | 27 | |
| 10 | 2012 | 23 | |
| 11 | 2004 | 23 | |
| 12 | 2022 | 17 | |
| 13 | 1952 | 15 | |
| 14 | 2022 | 14 | |
| 15 | 2016 | 14 | |
| 16 | 2022 | 13 | |
| 17 | 2016 | 13 | |
| 18 | 2017 | 13 | |
| 19 | 2018 | 12 | |
| 20 | 2020 | 11 |
About Lars Erichsen
Lars Erichsen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Nephrology, Pulmonary and Respiratory Medicine and Physiology, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Diabetes Management and Research (5 papers), Renal and related cancers (4 papers), Renal Diseases and Glomerulopathies (4 papers), Diabetes Treatment and Management (3 papers), Renal cell carcinoma treatment (2 papers), Chemical Synthesis and Characterization (2 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (528 citations), Pharmacology (164 citations), Urology (47 citations), Endocrine and Autonomic Systems (43 citations) and Physiology (152 citations). Lars Erichsen has collaborated with scholars based in Germany, Denmark and United States. Frequent co-authors include Hanne Haahr, Sue D. Pedersen, Thomas Danne, Thomas R. Pieber, Kristian Vinter Juul, Tim Heise, Chantal Mathieu, Melanie J. Davies, Juan P. Frías and Filip K. Knop. Their work appears in journals such as International Journal of Molecular Sciences, Cells, Scientific Reports, The Lancet and Die Naturwissenschaften.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.